{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-042937","form_type":"8-K","ticker":"NGNE","cik":"0001404644","company_name":"Neurogene Inc.","filed_at":"2022-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.323208+00:00","generated_at":"2026-06-27T07:54:59.079700+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Neoleukin CFO Robert Ho resigns effective March 1, 2022","bullets":["CFO and Corporate Secretary Robert Ho notified intent to resign to pursue another opportunity.","Resignation effective March 1, 2022; no successor named in the filing.","Company provided no details on interim or permanent replacement plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-042937","json":"https://secwatch.observer/filing/0001193125-22-042937.json","markdown":"https://secwatch.observer/filing/0001193125-22-042937.md","text":"https://secwatch.observer/filing/0001193125-22-042937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404644/000119312522042937/0001193125-22-042937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404644/000119312522042937/d282321d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:54:59.079700+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd3b8158c6","claim":"Robert Ho departed as Chief Financial Officer and Corporate Secretary at Neurogene Inc..","evidence_excerpt":"On February 14, 2022, Neoleukin Therapeutics, Inc. (the “Company”) received notice from Robert Ho of his intention to resign as the Company’s Chief Financial Officer and Corporate Secretary to pursue another opportunity, effective March 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1404644/000119312522042937/0001193125-22-042937-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Chief Financial Officer and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}